395 related articles for article (PubMed ID: 22812553)
1. Personalized medicine policy challenges: measuring clinical utility at point of care.
van Rooij T; Wilson DM; Marsh S
Expert Rev Pharmacoecon Outcomes Res; 2012 Jun; 12(3):289-95. PubMed ID: 22812553
[TBL] [Abstract][Full Text] [Related]
2. Role of genomics on the path to personalized medicine.
Tremblay J; Hamet P
Metabolism; 2013 Jan; 62 Suppl 1():S2-5. PubMed ID: 23021037
[TBL] [Abstract][Full Text] [Related]
3. Personalized medicine and the role of health economics and outcomes research: issues, applications, emerging trends, and future research.
O'Donnell JC
Value Health; 2013; 16(6 Suppl):S1-3. PubMed ID: 24034305
[TBL] [Abstract][Full Text] [Related]
4. Overcoming regulatory and economic challenges facing pharmacogenomics.
Cohen JP
N Biotechnol; 2012 Sep; 29(6):751-6. PubMed ID: 22370122
[TBL] [Abstract][Full Text] [Related]
5. [Translational approach for pharmacogenomics and personalized medicine].
Zhang W; Zhou HH
Yao Xue Xue Bao; 2011 Jan; 46(1):1-5. PubMed ID: 21465801
[TBL] [Abstract][Full Text] [Related]
6. Key aspects of health system change on the path to personalized medicine.
Downing GJ
Transl Res; 2009 Dec; 154(6):272-6. PubMed ID: 19931192
[TBL] [Abstract][Full Text] [Related]
7. Challenge of personalized health care: to what extent is medicine already individualized and what are the future trends?
Fierz W
Med Sci Monit; 2004 May; 10(5):RA111-23. PubMed ID: 15114285
[TBL] [Abstract][Full Text] [Related]
8. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
[TBL] [Abstract][Full Text] [Related]
9. Regulation, reimbursement, and the long road of implementation of personalized medicine--a perspective from the United States.
Frueh FW
Value Health; 2013; 16(6 Suppl):S27-31. PubMed ID: 24034309
[TBL] [Abstract][Full Text] [Related]
10. Emerging landscape of genomics in the Electronic Health Record for personalized medicine.
Ullman-Cullere MH; Mathew JP
Hum Mutat; 2011 May; 32(5):512-6. PubMed ID: 21309042
[TBL] [Abstract][Full Text] [Related]
11. Personalized health care and health information technology policy: an exploratory analysis.
Wald JS; Shapiro M
Stud Health Technol Inform; 2013; 192():622-6. PubMed ID: 23920631
[TBL] [Abstract][Full Text] [Related]
12. Clinical practice on the horizon: personalized medicine.
Chadwell K
Clin Nurse Spec; 2013; 27(1):36-43. PubMed ID: 23222027
[TBL] [Abstract][Full Text] [Related]
13. Personalized health care: from theory to practice.
Snyderman R
Biotechnol J; 2012 Aug; 7(8):973-9. PubMed ID: 22180345
[TBL] [Abstract][Full Text] [Related]
14. Group-based and personalized care in an age of genomic and evidence-based medicine: a reappraisal.
Maglo KN
Perspect Biol Med; 2012; 55(1):137-54. PubMed ID: 22643722
[TBL] [Abstract][Full Text] [Related]
15. The intersection of biotechnology and pharmacogenomics: health policy implications.
Phillips KA
Health Aff (Millwood); 2006; 25(5):1271-80. PubMed ID: 16966723
[TBL] [Abstract][Full Text] [Related]
16. Prospects of personalized medicine in cardiovascular diseases.
Lenfant C
Metabolism; 2013 Jan; 62 Suppl 1():S6-10. PubMed ID: 22999711
[TBL] [Abstract][Full Text] [Related]
17. Personalized medicine in women's obesity prevention and treatment: implications for research, policy and practice.
Yang N; Ginsburg GS; Simmons LA
Obes Rev; 2013 Feb; 14(2):145-61. PubMed ID: 23114034
[TBL] [Abstract][Full Text] [Related]
18. Implementation of genomic medicine in a health care delivery system: a value proposition?
Wade JE; Ledbetter DH; Williams MS
Am J Med Genet C Semin Med Genet; 2014 Mar; 166C(1):112-6. PubMed ID: 24619641
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomics, personalized medicine, and heart failure.
Mestroni L; Taylor MR
Discov Med; 2011 Jun; 11(61):551-61. PubMed ID: 21712021
[TBL] [Abstract][Full Text] [Related]
20. Reflections on market access for personalized medicine: recommendations for Europe.
Payne K; Annemans L
Value Health; 2013; 16(6 Suppl):S32-8. PubMed ID: 24034310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
